medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2018, Number 5

<< Back Next >>

Rev Invest Clin 2018; 70 (5)

Genomics and Systems Biology Approaches in the Study of Lipid Disorders

Rodríguez A, Pajukanta P

Language: English
References: 38
Page: 217-223
PDF size: 175.44 Kb.


ABSTRACT

Cardiovascular disease (CVD) is a broad definition for diseases of the heart and blood vessels with high mortality and morbidity worldwide. Atherosclerosis and hypertension are the most common causes of CVD, and multiple factors confer the susceptibility. Some of the predisposing factors are modifiable such as diet, smoking, and exercise, whereas others, including age, sex, and individual’s genetic variations contributing to the CVD composition traits, are non-modifiable. This latter group includes serum lipid traits. High serum lipid levels, specifically high levels of serum low-density lipoprotein cholesterol and triglycerides, are well-established key risk factors of atherosclerosis. This review will discuss genomics and systems biology approaches in the study of common dyslipidemias. The non-Mendelian forms of dyslipidemias are highly complex, and the molecular mechanisms underlying these polygenic lipid disorders are estimated to involve hundreds of genes. Interactions between the different genes and environmental factors also contribute to the clinical outcomes; however, very little is known about these interactions and their molecular mechanisms. To better address the complex genetic architecture and multiple properties leading to high serum lipid levels, networks and systems approach combining information at genomic, transcriptomics, methylomics, proteomics, metabolomics, and phenome level are being developed, with the ultimate goal to elucidate the cascade of dynamic changes leading to CVD in humans.


REFERENCES

  1. International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature. 2004;431:931-45.

  2. The International HapMap Consortium. A haplotype map of the human genome. Nature. 2005;437:1299-320.

  3. The 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature. 2010;467:1061-73.

  4. Visscher PM, Wray NR, Zhang Q, et al. 10 years of GWAS discovery: biology, function, and translation. Am J Hum Genet. 2017;101:5-22.

  5. Schunkert H, König IR, Kathiresan S, et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 2011;43:333-8.

  6. Weissglas-Volkov D, Pajukanta P. Genetic causes of high and low serum HDL-cholesterol. J Lipid Res. 2010;51:2032-57.

  7. MacLellan WR, Wang Y, Lusis AJ. Systems-based approaches to cardiovascular disease. Nat Rev Cardiol. 2012;9:172-84.

  8. Sun YV. Integration of biological networks and pathways with genetic association studies. Hum Genet. 2012;131:1677-86.

  9. Kathiresan S, Willer CJ, Peloso GM, et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet. 2009; 41:56-65.

  10. Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010;466:707-13.

  11. Johansen CT, Wang J, McIntyre AD, et al. Excess of rare variants in non-genome-wide association study candidate genes in patients with hypertriglyceridemia. Circ Cardiovasc Genet. 2012; 5:66-72.

  12. Civelek M, Wu Y, Pan C, et al. Genetic regulation of adipose gene expression and cardio-metabolic traits. Am J Hum Genet. 2017; 100:428-43.

  13. Belbin GM, Odgis J, Sorokin EP, et al. Genetic identification of a common collagen disease in Puerto Ricans via identity-by-descent mapping in a health system. Elife 2017;6:e25060.

  14. Hoffmann TJ, Theusch E, Haldar T, et al. A large electronichealth- record-based genome-wide study of serum lipids. Nat Genet. 2018;50:401-13.

  15. Ng SB, Buckingham KJ, Lee C, et al. Exome sequencing identifies the cause of a Mendelian disorder. Nat Genet. 2010;42:30-5.

  16. Reddy MV, Iatan I, Weissglas-Volkov D, et al. Exome sequencing identifies 2 rare variants for low high-density lipoprotein cholesterol in an extended family. Circ Cardiovasc Genet. 2012;5:538-46.

  17. Pickrell JK, Marioni JC, Pai AA, et al. Understanding mechanisms underlying human gene expression variation with RNA sequencing. Nature. 2010;464:768-72.

  18. Pickrell JK, Gilad Y, Pritchard JK. Comment on “Widespread RNA and DNA sequence differences in the human transcriptome”. Science. 2012;335:1302.

  19. Gusev A, Ko A, Shi H, et al. Integrative approaches for largescale transcriptome-wide association studies. Nat Genet. 2016;48:245-52.

  20. Tukiainen T, Kettunen J, Kangas AJ, et al. Detailed metabolic and genetic characterization reveals new associations for 30 known lipid loci. Hum Mol Genet. 2012;21:1444-55.

  21. Inouye M, Ripatti S, Kettunen J, et al. Novel loci for metabolic networks and multi-tissue expression studies reveal genes for atherosclerosis. PLoS Genet. 2012;8:e1002907.

  22. International Consortium for Blood Pressure Genome-Wide Association Studies, Ehret GB, Munroe PB, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011;478:103-9.

  23. Hormozdiari F, van de Bunt M, Segrè AV, et al. Colocalization of GWAS and eQTL signals detects target genes. Am J Hum Genet. 2016;99:1245-60.

  24. Kichaev G, Roytman M, Johnson R, et al. Improved methods for multi-trait fine mapping of pleiotropic risk loci. Bioinformatics. 2017;33:248-55.

  25. Degner JF, Pai AA, Pique-Regi R, et al. DNase I sensitivity QTLs are a major determinant of human expression variation. Nature. 2012;482:390-94.

  26. Roman TS, Mohlke KL. Functional genomics and assays of regulatory activity detect mechanisms at loci for lipid traits and coronary artery disease. Curr Opin Genet Dev. 2018;50:52-9.

  27. Li YI, van de Geijn B, Raj A, et al. RNA splicing is a primary link between genetic variation and disease. Science. 2016;352:600-4.

  28. Taneera J, Lang S, Sharma A, et al. A systems genetics approach identifies genes and pathways for Type 2 diabetes in human islets. Cell Metab. 2012;16:122-34.

  29. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545-50.

  30. Zhang B, Horvath S. A general framework for weighted gene coexpression network analysis. Stat Appl Genet Mol Biol. 2005;4:Article: 17.

  31. Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.

  32. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44-57.

  33. Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37:1-13.

  34. Haas BE, Horvath S, Pietiläinen KH, Cantor RM, Nikkola E, Weissglas- Volkov D, et al. Adipose co-expression networks across finns and Mexicans identify novel triglyceride-associated genes. BMC Med Genomics. 2012;5:61.

  35. van Eijk KR, de Jong S, Boks MP, et al. Genetic analysis of DNA methylation and gene expression levels in whole blood of healthy human subjects. BMC Genomics. 2012;13:636.

  36. Voineagu I, Wang X, Johnston P, et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature. 2011;474:380-4.

  37. Fuller TF, Ghazalpour A, Aten JE, et al. Weighted gene co-expression network analysis strategies applied to mouse weight. Mamm Genome. 2007;18:463-72.

  38. Chen R, Mias GI, Li-Pook-Than J, et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell. 2012; 148:1293-307.




2020     |     www.medigraphic.com